Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Fred Levine who wrote (863)	2/6/1998 5:14:00 PM
From: David Mckenna	Read Replies (2) \| Respond to of 1605

EECP therapy is not a widely accepted method of treatment for patients with angina. My father is currently at Mass General Hospital, he is not a candidate for bypass (already had 3) or angioplasty (already had 3) he is left with TMR, which uses a laser to make holes in the heart, these holes relieve the angina as they promote new vein growth or the last option which is a transplant. After I inquired about using EECP, the doctors (4 different) were all very skeptical and suggested that this was just an entrepreneurial venture and long term would pan out to be a scam. One doctor felt there maybe short term benefits but not long term and the same type of benefits could be achieved thru excersize. This may not be an option for my father because he has PROXIMAL disease versus DISTAL disease. (Proximal disease is in major arteries, while distal disease occurs in smaller veins around the heart). Still searching for alternatives- Dave